UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Graft failure in the modern era of allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.537-543

2013

Volltextzugriff (PDF)

Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.706-715

2012

Volltextzugriff (PDF)

Increased β‐haemolytic group A streptococcal M6 serotype and streptodornase B‐specific cellular immune responses in Swedish narcolepsy cases

Journal of internal medicine, 2015-09, Vol.278 (3), p.264-276

2015

Volltextzugriff (PDF)

BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (8), p.737-742

2008

Volltextzugriff (PDF)

Music therapy can lower the heart rates of severely sick children

Acta Paediatrica, 2016-10, Vol.105 (10), p.1225-1230

2016

Volltextzugriff (PDF)

A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (9), p.785-790

2008

Volltextzugriff (PDF)

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 1999-10, Vol.24 (8), p.823-830

1999

Volltextzugriff (PDF)

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

Bone marrow transplantation (Basingstoke), 1998-10, Vol.22 (8), p.755-761

1998

Volltextzugriff (PDF)

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases

Bone marrow transplantation (Basingstoke), 2007-04, Vol.39 (7), p.383-388

2007

Volltextzugriff (PDF)

Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (11), p.769-771

2008

Volltextzugriff (PDF)

Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-09, Vol.36 (6), p.511-516

2005

Volltextzugriff (PDF)

Intraosseous compared to intravenous infusion of allogeneic bone marrow

Bone marrow transplantation (Basingstoke), 1998-02, Vol.21 (4), p.331-335

1998

Volltextzugriff (PDF)

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies

Transplantation, 1998-09, Vol.66 (5), p.620

1998

Volltextzugriff (PDF)

Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation

Transplantation, 2004-07, Vol.78 (1), p.122

2004

Volltextzugriff (PDF)

Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial

Bone marrow transplantation (Basingstoke), 2000-11, Vol.26 (10), p.1057-1060

2000

Volltextzugriff (PDF)

Erratum: Graft failure in the modern era of allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.616-616

2013

Volltextzugriff (PDF)

Graft failure in the modern era of allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.616

2013

Volltextzugriff (PDF)

Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition

Transplantation, 2008-04, Vol.85 (7), p.1000

2008

Volltextzugriff (PDF)

Allergic reactions and other rare side-effects of liposomal amphotericin

The Lancet (British edition), 1994-10, Vol.344 (8930), p.1156-1157

1994

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center

Transplantation, 2006-03, Vol.81 (5), p.718

2006

Volltextzugriff (PDF)

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients

Mycoses, 1996-05, Vol.39 (5-6), p.185-193

1996

Volltextzugriff (PDF)

Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades

Transplantation, 2006-06, Vol.81 (11), p.1600

2006

Volltextzugriff (PDF)

Increased Costs After Allogeneic Haematopoietic SCT Are Associated with Major Complications and Re-Transplantation

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, Vol.18 (2), p.S339-S339

2012

Volltextzugriff (PDF)

Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation

Pediatric transplantation, 1997-11, Vol.1 (2), p.124

1997

Volltextzugriff (PDF)

Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis

Cell metabolism, 2015-09, Vol.22 (3), p.408-417

2015

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(56)
Tagungsberichte
(16)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Graft failure in the modern era of allogeneic hematopoietic SCT

Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation

Increased β‐haemolytic group A streptococcal M6 serotype and streptodornase B‐specific cellular immune responses in Swedish narcolepsy cases

BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts

Music therapy can lower the heart rates of severely sick children

A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases

Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose

Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation

Intraosseous compared to intravenous infusion of allogeneic bone marrow

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies

Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation

Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial

Erratum: Graft failure in the modern era of allogeneic hematopoietic SCT

Graft failure in the modern era of allogeneic hematopoietic SCT

Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition

Allergic reactions and other rare side-effects of liposomal amphotericin

Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients

Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades

Increased Costs After Allogeneic Haematopoietic SCT Are Associated with Major Complications and Re-Transplantation

Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation

Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis

Suchergebnisse filtern